Queensland Health selects ProVation for electronic Endoscopy Reporting solution
Queensland Health is set to install new electronic Endoscopy Reporting software at its facilities that perform endoscopy services.
Global Health IT company, Wolters Kluwer Health, the parent company of Ovid Technologies, announced on January 7 that Queensland Health had licensed ProVation MD for Gastroenterology and ProVation MultiCaregiver. Both products will play a key role in the documentation and reporting required by the National Bowel Cancer Screening Program (NBCSP), which screens people turning 50, 55 or 65 before December 2010.
Specifically, the ProVation MD software will electronically capture procedure images taken during a patient’s screening, and will integrate those images and note findings directly into the patient’s report. The MultiCaregiver software will interface with vitals monitors, allowing caregivers, including nurses and specialists, to capture procedure data throughout the duration of the patient’s care. All information will automatically be stored to the ProVation MD database.
A company spokesman said the software would integrate seamlessly with other software already operating at Queensland Health by interfacing with current front and back end medical software systems.
“ProVation will take front end feeds of patient demographic and scheduling data from Patient Administration Systems and return information to the back end Medical record systems via a HL7 interface language and protocols,” the spokesman said.
Site testing of the new software will be undertaken in the first half of 2009, and the company expects the software to be implemented in most Queensland Health sites by December 2009.
The company said the software’s benefits to health carers and patients will be noticed immediately.
“The end benefits of the software are noticed from the first use of the software and include: greater efficiency and faster, more accurate completion of documentation, elimination of dictation, inclusion of procedure images with the patient record, extensive data reporting capabilities for clinical research, administrative reporting and outcomes tracking and increased physician satisfaction,” the company said.
Queensland’s Health Minister Stephen Robertson said the software will help Queensland Health successfully detect and treat bowel cancer.
“Bowel cancer can be treated successfully if detected in its early stages, but currently fewer than 40 percent of bowel cancers are detected early,” he said.
“A critical part of a population screening program is timely data collection and monitoring of quality.
“ProVation software will allow us to streamline our documentation and data reporting process considerably,” he said.
Wulters Kluwer, which has its global headquarters in Amsterdam, has been operating in Australia since 1994. The company acquired ProVation Medical in 2006.
Wolters Kluwer Health and ProVation Medical international sales director Allan Roberts said the company was “honoured to have been chosen as Queensland’s vendor of choice for endoscopy documentation and data reporting.”
Posted in Australian eHealth